<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Erasca, Inc.</title>
    <link>https://www.biospace.com/employer/1915880/erasca-inc</link>
    <description>Erasca, Inc.</description>
    <language>en-US</language>
    <lastBuildDate>Thu, 18 Jun 2020 17:20:59 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/1915880/erasca-inc.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>BioSpace Movers &amp; Shakers, June 19</title>
      <link>https://www.biospace.com/biospace-movers-and-shakers-june-19</link>
      <dc:creator>Alex Keown</dc:creator>
      <description>Biopharma and life sciences companies bolster their executive leadership teams and boards with these Movers &amp; Shakers.</description>
      <pubDate>Thu, 18 Jun 2020 17:20:59 GMT</pubDate>
      <guid>https://www.biospace.com/biospace-movers-and-shakers-june-19</guid>
    </item>
    <item>
      <title>BioSpace Movers &amp; Shakers, Aug. 28</title>
      <link>https://www.biospace.com/biospace-mover-and-shakers-aug-28</link>
      <dc:creator>Alex Keown</dc:creator>
      <description>Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers &amp; Shakers.</description>
      <pubDate>Fri, 28 Aug 2020 16:45:43 GMT</pubDate>
      <guid>https://www.biospace.com/biospace-mover-and-shakers-aug-28</guid>
    </item>
    <item>
      <title>Clinical Catch-Up: September 20-24</title>
      <link>https://www.biospace.com/clinical-catch-up-september-20-24</link>
      <dc:creator>Mark Terry</dc:creator>
      <description>There was still some carryover from the European Society of Medical Oncology Congress 2021, but there was plenty of other clinical trial news last week. Here’s a look.</description>
      <pubDate>Fri, 24 Sep 2021 13:30:37 GMT</pubDate>
      <guid>https://www.biospace.com/clinical-catch-up-september-20-24</guid>
    </item>
    <item>
      <title>Clinical Catch-Up: December 11-17</title>
      <link>https://www.biospace.com/clinical-catch-up-december-11-17</link>
      <dc:creator>Mark Terry</dc:creator>
      <description>It was an enormously busy week with plenty of announcements from the American Society of Hematology meeting and numerous companies working to get the news out ahead of the holidays and year-end. Here’s a look.</description>
      <pubDate>Fri, 17 Dec 2021 21:41:11 GMT</pubDate>
      <guid>https://www.biospace.com/clinical-catch-up-december-11-17</guid>
    </item>
    <item>
      <title>23andMe, EQRx Lead IPO Rush in 2021</title>
      <link>https://www.biospace.com/23andme-eqrx-lead-ipo-rush-in-2021</link>
      <dc:creator>Alex Keown</dc:creator>
      <description>The year kicked off with a bang as multiple companies raced to a public listing.</description>
      <pubDate>Mon, 20 Dec 2021 14:33:11 GMT</pubDate>
      <guid>https://www.biospace.com/23andme-eqrx-lead-ipo-rush-in-2021</guid>
    </item>
    <item>
      <title>Allogene, Progenity, Adaptive Phage Tout New Top Executives</title>
      <link>https://www.biospace.com/biospace-movers-and-shakers-april-29th</link>
      <dc:creator>Alex Keown</dc:creator>
      <description>Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers &amp; Shakers.</description>
      <pubDate>Thu, 28 Apr 2022 20:32:28 GMT</pubDate>
      <guid>https://www.biospace.com/biospace-movers-and-shakers-april-29th</guid>
    </item>
    <item>
      <title>Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing (Updated)</title>
      <link>https://www.biospace.com/pfizer-inks-expanded-partnership-with-erasca-target-pancreatic-colorectal-cancer</link>
      <dc:creator>Tristan Manalac</dc:creator>
      <description>Erasca announced that it was expanding its existing partnership with Pfizer to assess its ERAS-007 in combination with the Big Pharma’s Ibrance.</description>
      <pubDate>Thu, 20 Oct 2022 15:14:28 GMT</pubDate>
      <guid>https://www.biospace.com/pfizer-inks-expanded-partnership-with-erasca-target-pancreatic-colorectal-cancer</guid>
    </item>
    <item>
      <title>Erasca Raises $200 Million Series B Financing</title>
      <link>https://www.biospace.com/erasca-raises-200-million-series-b-financing</link>
      <description>Erasca, a company whose mission is to erase cancer, today announced the completion of a $200 million Series B financing round co-led by ARCH Venture Partners and Cormorant Asset Management. New investors participating in this financing inc</description>
      <pubDate>Mon, 27 Apr 2020 12:06:12 GMT</pubDate>
      <guid>https://www.biospace.com/erasca-raises-200-million-series-b-financing</guid>
    </item>
    <item>
      <title>Erasca Expands Leadership Team with Key Regulatory and Clinical Appointments</title>
      <link>https://www.biospace.com/erasca-expands-leadership-team-with-key-regulatory-and-clinical-appointments</link>
      <description>Erasca, a company whose mission is to erase cancer, today announced the expansion of its leadership team with the appointment of Bao Truong as vice president of regulatory affairs and David Luo as vice president of clinical research and operations. “We are delighted to continue attracti</description>
      <pubDate>Tue, 16 Jun 2020 12:06:15 GMT</pubDate>
      <guid>https://www.biospace.com/erasca-expands-leadership-team-with-key-regulatory-and-clinical-appointments</guid>
    </item>
    <item>
      <title>Erasca Recruits Michael Varney, Ph.D., as Chairman of Research &amp; Development and Scientific Advisory Board Member</title>
      <link>https://www.biospace.com/erasca-recruits-michael-varney-ph-d-as-chairman-of-research-and-amp-development-and-scientific-advisory-board-member</link>
      <description>Erasca, a company whose mission is to erase cancer, today announced that Michael Varney, Ph.D., has joined the organization’s Scientific Advisory Board (SAB) and will also serve as Chairman of Research &amp; Development (R&amp;D). In these roles, Dr. Varney will help advance Erasca’s drug discovery portfolio by providing strategic input on portfolio o</description>
      <pubDate>Mon, 24 Aug 2020 12:06:10 GMT</pubDate>
      <guid>https://www.biospace.com/erasca-recruits-michael-varney-ph-d-as-chairman-of-research-and-amp-development-and-scientific-advisory-board-member</guid>
    </item>
  </channel>
</rss>
